ClinicalTrials.gg
RecruitingNCT07225010Updated Mar 6, 2026

Tele-PCIT for Healthy Relationships in Families At-Risk

An interventional study of Telehealth Parent Child Interaction Therapy and Telehealth Parent Child Interaction Therapy (Delayed Start) in Disruptive Behavior and Pediatrics, sponsored by Medical University of South Carolina. Recruiting at 1 site in United States. Open to participants aged 2 Years to 7 Years. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
2 Years to 7 Years
Sex
All
01

Study summary

The study will examine Parent Child Interaction Therapy (PCIT) delivered via telehealth (Tele-PCIT) for young children at risk for adverse childhood experiences and/or trauma exposure.

Read the detailed description

This randomized controlled trial evaluates the feasibility, acceptability, engagement, and initial efficacy of time-limited Parent Child Interaction Therapy (PCIT) delivered via telehealth (Tele-PCIT) across 40 young children at risk for adverse childhood experiences and/or trauma exposure. The study compares outcomes between families receiving Tele-PCIT (n = 20) and those assigned to a waitlist control (n = 20). All families will complete baseline, post, and follow-up evaluations to assess child behavioral outcomes, parenting outcomes, and trauma symptoms. In order to be eligible children are between 2 and 7 years of age presenting with behavioral concerns and scoring at-risk on childhood averse events measures.

02

Conditions studied

  • Disruptive Behavior
  • Pediatrics

Browse trials for

03

In context

Problem Behavior

178 studies on the registry are indexed under Problem Behavior; 47 are open to participants now.

This study's planned enrollment of 50 is below the median of 90 across 165 interventional studies indexed under Problem Behavior.

Browse Problem Behavior studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 874 studies on the registry; 166 are open to participants now.

Of its 131 completed or terminated interventional studies of FDA-regulated products, 104 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Child participants must:

    • Be between 2:0-6:11 years old
    • Have elevated levels of disruptive behavior problems as defined by the Eyberg Child Behavior Inventory (ECBI)
    • Have receptive language appropriate for PCIT (approximately 2-years old)
    • Medicaid eligible, or be uninsured
    • Score of 1 or greater on an ACEs (adverse childhood experiences) measure (PEARLS)
  • Parent participants must:

    • Be the child's legal guardian
    • Be able to provide consent for themselves (i.e., have decision making capacity and do not need a legally authorized representative themselves).
    • Must be living with the child

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Tele-PCIT

    Families in the Tele-PCIT condition will recieve a time limited (10 session) version of PCIT via telehealth.

    Behavioral: Telehealth Parent Child Interaction Therapy

  • Other
    Waitlist Control

    Delayed Start of Tele-PCIT

    Behavioral: Telehealth Parent Child Interaction Therapy (Delayed Start)

Interventions

  • BehavioralTelehealth Parent Child Interaction Therapy

    During tele-PCIT, therapists coach parents on parenting strategies while they play with their child during one hour weekly sessions. The first phase of therapy focuses on increasing positive behaviors and the second phase focuses on decreasing negative behaviors with discipline strategies. The therapist and the family will be connected through a video feed on either a phone, tablet, or computer and a Bluetooth headset.

    Also known as: Tele-PCIT, iPCIT

  • BehavioralTelehealth Parent Child Interaction Therapy (Delayed Start)

    Delayed start of 12-weeks for delivery of Tele-PCIT. During tele-PCIT, therapists coach parents on parenting strategies while they play with their child during one hour weekly sessions. The first phase of therapy focuses on increasing positive behaviors and the second phase focuses on decreasing negative behaviors with discipline strategies. The therapist and the family will be connected through a video feed on either a phone, tablet, or computer and a Bluetooth headset.

    Also known as: Tele-PCIT, iPCIT

06

What researchers measure

Primary outcomes

  1. Parenting Practices

    Measured by the Parenting Scale. The parenting scale is comprised of 30 items rated 1-7 with specific items being averaged to create composites for Laxness, Verbosity, and Overreactivity. Higher scores on each scale indicate higher levels of each parenting behavior.

    Time frame: Assessed at Baseline, 12-weeks post baseline, and at a 3-month follow-up

  2. Child Behavior

    Measured by Eyberg Child Behavior Inventory. The ECBI is comprised of 36 items ranging from 1 to 7 and the overall score has a a minimum of 36 and maximum of 252 with higher scores indicating higher behavioral challenges.

    Time frame: Assessed at Baseline, 12-weeks post baseline, and at a 3-month follow-up

  3. Trauma Related Symptoms

    Measured by the Child and Adolescent Trauma Screen. The CATS contains 15 items measuring traumatic events, 20 items measuring DSM-5 PTSD symptoms, and 5 items measuring psychosocial functioning, with a range of 0-48 and higher scores indicating greater symptoms.

    Time frame: Assessed at Baseline, 12-weeks post baseline, and at a 3-month follow-up

07

Study locations

1 of 1 sites recruiting
  • Rutledge Tower
    Charleston, South Carolina 29425, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07225010
Collaborators
The Duke Endowment
Responsible party
Rosmary Ros-Demarize (Associate Professor-Faculty, Medical University of South Carolina) — Principal investigator
First posted
Nov 5, 2025
Start date
Feb 12, 2026
Primary completion
Aug 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Mar 6, 2026

Study contacts

Rosmary Ros-Demarize, Ph.D.
principal investigator · Medical University of South Carolina

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion